Evidence map›Paper›PMID 35278482›Full record

ArticleThe Journal of infection2022

Comparative T and B immune responses of four different anti-COVID-19 vaccine strategies 6 months after vaccination.

Benjamin Bonnet, Hélène Chabrolles, Christine Archimbaud, Amélie Brebion, Maud Godignon, Frédéric Dutheil, Céline Lambert, Justine Cosme, Audrey Mirand, Amandine Ollier and 5 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023
    Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Benjamin BonnetImmunology Department, CHU Clermont-Ferrand, Service d'immunologie, Clermont-Ferrrand, Clermont-Ferrand F-63000, France; Clermont Auvergne University, UMR1019 UNH, ECREIN, Clermont-Ferrand, France. Electronic address: b_bonnet@chu-clermontferrand.fr.
Hélène ChabrollesCHU Clermont-Ferrand, 3IHP, Virology Department, Clermont-Ferrand, France; Clermont Auvergne University, CNRS UMR 6023, LMGE, Clermont-Ferrand, France.
Christine ArchimbaudCHU Clermont-Ferrand, 3IHP, Virology Department, Clermont-Ferrand, France; Clermont Auvergne University, CNRS UMR 6023, LMGE, Clermont-Ferrand, France.
Amélie BrebionCHU Clermont-Ferrand, 3IHP, Virology Department, Clermont-Ferrand, France.
Maud GodignonImmunology Department, CHU Clermont-Ferrand, Service d'immunologie, Clermont-Ferrrand, Clermont-Ferrand F-63000, France.
Frédéric DutheilCHU Clermont-Ferrand, Preventive and Occupational Medicine, Clermont-Ferrand, France; Clermont Auvergne University, CNRS, LaPSCo Physiological and Psychosocial Stress, Clermont-Ferrand, France.
Céline LambertCHU Clermont-Ferrand, DRCI, Biostatistics unit, Clermont-Ferrand, France.
Justine CosmeImmunology Department, CHU Clermont-Ferrand, Service d'immunologie, Clermont-Ferrrand, Clermont-Ferrand F-63000, France.
Audrey MirandCHU Clermont-Ferrand, 3IHP, Virology Department, Clermont-Ferrand, France; Clermont Auvergne University, CNRS UMR 6023, LMGE, Clermont-Ferrand, France.
Amandine OllierCHU Clermont-Ferrand, 3 IHP, Clinical Research and Innovation Direction, Clermont-Ferrand, France.
Bruno PereiraCHU Clermont-Ferrand, DRCI, Biostatistics unit, Clermont-Ferrand, France.
Christel RegagnonCHU Clermont-Ferrand, 3IHP, Virology Department, Clermont-Ferrand, France.
Magali VidalInfectious Diseases Department, CHU Clermont-Ferrand, 3 IHP, Clermont-Ferrand, France.
Bertrand EvrardImmunology Department, CHU Clermont-Ferrand, Service d'immunologie, Clermont-Ferrrand, Clermont-Ferrand F-63000, France; Clermont Auvergne University, UMR1019 UNH, ECREIN, Clermont-Ferrand, France.
Cécile HenquellCHU Clermont-Ferrand, 3IHP, Virology Department, Clermont-Ferrand, France; Clermont Auvergne University, CNRS UMR 6023, LMGE, Clermont-Ferrand, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19COVID-19 VaccinesAntibodies, ViralHumansImmunityImmunity, CellularImmunity, HumoralSARS-CoV-2Spike Glycoprotein, CoronavirusVaccinationAntibodies, ViralCOVID-19 VaccinesSpike Glycoprotein, CoronavirusB-cell responsesInterferon gamma (IFN-γ)mRNA vaccinesSARS-CoV-2T-cell responses

Identifiers

PMID35278482
PMCPMC8905884

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.